From Awareness to Action: Pioneering Solutions for Women's UTI Challenges in the Era of Precision Medicine
- PMID: 39359902
- PMCID: PMC11446210
- DOI: 10.2147/IJWH.S477476
From Awareness to Action: Pioneering Solutions for Women's UTI Challenges in the Era of Precision Medicine
Abstract
This article aims to bring clinicians' awareness to the widespread impact of urinary tract infection (UTI) on the lives of women and to the advances that offer hope for future improvements in the diagnosis and management of UTI. Thanks to physiological, anatomical, and lifestyle factor differences, women face heightened vulnerability to UTIs compared to men. In fact, women are four times more likely than men to develop a UTI and around half of these women encounter UTI recurrence, which is a significant source of both physical and psychosocial burdens. Despite the current shortcomings in diagnosis and management, emerging diagnostic technologies promise to identify UTIs more accurately and rapidly, offering women hope for a revolution in UTI management. Meanwhile, clinicians have the opportunity to reduce the psychosocial burden by recognizing the value of patients' lived experiences and ensuring their care plan is in alignment with their patients' goals and expectations for medical care.
Keywords: mass spectrometry; metagenomic next-generation sequencing; multiplex-polymerase chain reaction; urinary tract infection; urine culture; women’s health.
© 2024 Haley and Luke.
Conflict of interest statement
Luke reports patents (11,053,532, 10/160,991, and 11,746,371) licensed to Pathnostics; patents (18,351,286, 18,351,385, 17,830,227, 18,451,748, 17,178,091) pending to Pathnostics and both Haley and Luke are employees of Pathnostics which offers the Guidance UTI test for diagnosis and the determination of treatment options for those with complicated or recurrent UTI’s. The authors report no other conflicts of interest in this work.
References
-
- Larsen AW, Chen Y, Crandall KA, Icenhour CR, Valencia CA. Characterization of the Interstitial Cystitis/Bladder Pain Syndrome Microbiome in Clinically Diagnosed Patients. Clin Immunol Res. 2022;6(2). doi:10.33425/2639-8494.1047 - DOI
-
- Adelugba I, Siddiqui S, Aziz A, De EJB, Wolff G. Interstitial Cystitis/Bladder Pain Syndrome: what Today’s Urologist Should Know. Curr Bl Dysfunct Rep. 2023;18(1):16–28. doi:10.1007/s11884-022-00676-1 - DOI
-
- Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Physician. 2006;74(6):985–990. - PubMed
LinkOut - more resources
Full Text Sources